ARCHIVES

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Komen Foundation Grant Recipients Are Listed

August 13, 1993

NCI Oks Expanded Breast Cancer Low Fat Prevention Trial, Plans To End Stage 2 Adjuvant Low Fat Study

January 31, 1986

NTP Board Okays Three Cooperative Agreement Concepts, Including Corn Oil Carcinogens is Test

October 7, 1983

VIB CIDAC contract Extended, No Gaps In CANCERGRAMS

June 15, 1984

NCI CTEP Approved Trials For the Month of April

April 26, 2013

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998